George Graham
CIK: 0002082308
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BCPC
BALCHEM CORP
Officer
Discretionary Trading P&L
Holdings
About Graham George
Graham George (SEC CIK 0002082308) files insider reports with the SEC as SVP and Chief R&D Officer of BALCHEM CORP (BCPC).
Signal8 holds 3 ownership filings by Graham George (1 Form 3, 2 Form 4), filed between Oct 22, 2025 and Feb 13, 2026. Those filings report 2 transactions, from Oct 20, 2025 to Feb 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Graham George's filings is in MONTVALE, NJ.
Recent filings by Graham George
Other insiders filing for BALCHEM CORP (BCPC)
- Gilson Erin Leigh, Chief Accounting Officer
- van Gunsteren Job Leonard, SVP and GM, Specialty Products
- Reid Martin Luther, SVP Chief Supply Chain Officer
- Harris Theodore L, Chairman, President & CEO
- Backus William A., VP & Chief Accounting Officer
- Boned Frederic, SVP/GM, Human Nutri. & Health